The New Zealand AIDS Foundation (NZAF) says Kiwis with newly diagnosed HIV infections are being unfairly penalised by outdated policies denying them access to important medication. Currently people diagnosed with HIV in New Zealand cannot access medication until their CD4 cell (white blood cell) count has dropped below 500.
24 November 2016 | Newshub
A study launched in Yaoundé will test the latest generation of HIV treatment based on Dolutegravir under local conditions, with a view to establishing its viability in Africa. The results of the study are intended to inform the World Health Organization’s guidelines for the treatment of HIV patients in Africa. If successful, they will help to accelerate the opening of the market for these combinations to manufacturers of generic medicines and thereby reduce prices as well as improve access.
17 November 2016 | UNITAID
Each of an estimated 2.1 million Indians infected with the human immunodeficiency virus (HIV) should be getting a cocktail of drugs to prolong their lives and reduce infections, but no more than 44% do, the minister of health told the Lok Sabha (parliament’s lower house) in April 2016.
12 September 2016 | Firstpost
From today anyone who is HIV- positive can access ARVs from a state facility - good news for about 4million people living with the virus but not on medication. Until now only HIV-positive but people with CD4 counts lower than 500 (the measure of immune system strength) qualified for treatment under the Department of Health's treatment guidelines
01 September 2016 | TIMES Live
All people who tested positive to HIV from Manicaland and Matabeleland South provinces in June will immediately be placed on antiretroviral therapy regardless of their CD4 count as the country seeks to operationalise the latest World Health Organisation guidelines on treatment and care of HIV.
30 August 2016 | AllAfrica
People living with HIV would from October start anti-retroviral treatment straightaway given any CD4 cell count upon testing, the government has announced.
24 August 2016 | AllAfrica
In a report appearing in the July 12 issue of JAMA, an HIV/AIDS theme issue, Huldrych F. Gunthard, M.D., of University Hospital Zurich, Switzerland, and colleagues with the International Antiviral Society-USA panel, updated recommendations for the use of antiretroviral therapy in adults with established HIV infection, including when to start treatment, initial regimens, and changing regimens, along with recommendations for using antiretroviral drugs for preventing HIV among those at risk, including preexposure and postexposure prevention.
13 July 2016 | Science Daily
Antiviral treatment should be recommended for all those with HIV/AIDS under China's newly revised guidelines, said an online notice issued by the National Health and Family Planning Commission on Wednesday.
20 June 2016 | Asia One
This edition updates the 2013 consolidated guidelines on the use of antiretroviral drugs following an extensive review of evidence and consultations in mid-2015, shared at the end of 2015, and now published in full in 2016. It is being published in a changing global context for HIV and for health more broadly.
15 June 2016 | World Health Organization
The Government of South Africa has announced a major policy shift that will move the world faster towards the global 90–90–90 treatment target. On 10 May 2016, the South African Minister of Health, Aaron Motsoaledi, announced in his Health Budget Vote Speech to the Parliament of South Africa that the country will implement a new evidence-based policy of offering HIV treatment to all people living with HIV by September 2016.
16 May 2016 | UNAIDS